期刊文献+

食管癌贲门癌合并肝硬化7例同期手术治疗探讨 被引量:4

Carcinoma of Esophagus Cardia Cancer Associated with Cirrhosis 7 Cases Surgical Treatment Experience During the Same Period
下载PDF
导出
摘要 目的探讨食管癌贲门癌合并肝硬化患者同期实施食管胃吻合术和脾切除术的可行性。方法回顾2006年1月—2011年6月7例同期实施食管胃吻合术和脾切除术的临床资料。结果该组7例患者均经手术治愈,无一例死亡。术后1例发生颈部吻合口瘘,经治疗痊愈。术后随访1~5年,患者能从事轻体力劳动,无上消化道出血患者,无全血细胞减少病例。现在5例存活(生存5年1例﹑3年2例﹑1年2例﹑2例术后2年死于肝硬化相关肝昏迷)。结论食管癌贲门癌合并肝硬化同期行脾切除手术,一次手术治愈两种疾病,防治肝硬化所致的消化道出血和脾功能亢进所致全血细胞较少,提高了生活质量,值得临床推广。 Objective To investigate the carcinoma of esophagus cardia cancer associated with the same period of patients with liver cirrhosis implementation of esophagogastrostomy and splenectomy feasibility. Methods Retrospective 7 cases clinical material implemented esophagogastrostomy and splenectomy successively from January 2006 to June 2011. Results The 7 patients by surgery were cured, and no 1 case death. 1 case which ocurred cervical anastomotic fistula were recoveried after the treatment . All the cases were followed up from 1 to 5 years. Patients that were performed esophagogastric anastomosis andsplenectomy successively could engage in slight manual labor,and weren’t found upper gastrointestinal hemorrhage and pancytopenia.2 cases died of hepatic coma in 2years, Now 5 patients which no upper gastrointestinal hemorrhage and pancytopenia live . such as survival five years in 1, 3 years in 2 cases, 1 year in 2 cases. Conclusion The patients that were performed esophagogastric anastomosis and splenectomy successively are improved postoperative life quality and reduced the operation cost. The operation method deserved clinical application.
出处 《中外医疗》 2013年第10期15-15,17,共2页 China & Foreign Medical Treatment
关键词 食管癌 贲门癌 肝硬化 手术 Esophageal cancer Cardia cancer Liver cirrhosis Surgery
  • 相关文献

参考文献3

二级参考文献25

  • 1马慧,王豪,孙焱,郭芳,房继莲,邵杰,饶慧瑛,王剑,魏来.失代偿期肝硬化患者的终末期肝病模型预后分析[J].中华肝脏病杂志,2005,13(6):407-409. 被引量:43
  • 2Jun Ho Lee,Junuk Kim,Jae Ho Cheong,Woo Jin Hyung,Seung Ho Choi,Sung Hoon Noh.Gastric cancer surgery in cirrhotic patients: Result of gastrectomy with D2 lymph node dissection[J].World Journal of Gastroenterology,2005,11(30):4623-4627. 被引量:25
  • 3无.慢性乙型肝炎防治指南[J].实用肝脏病杂志,2006,9(1):8-18. 被引量:825
  • 4Chan HL, Tang JL, Tam W, et al. The efficacy of thymosin in the treatment of chronic hepatitisB virus infection: a meta -analysis [ J ]. Aliment Pharmacol Ther, 2001,15 (12): 1899 -1905.
  • 5Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end - stage liver disease [ J ]. Hepatology, 2001, 33(2):464-470.
  • 6Forman LM, LuceyMR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD[ J]. Hepatology, 2001,33 (2) : 473 - 475.
  • 7Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg. Today 1997,27:17-21.
  • 8Sirineck KR, Burk RR, Brown M, et al. Improving survival in patient with cirrhosis undergoing major abdominal operations. Arch. Surg, 1987,122:271-273.
  • 9Takeda J, Hashimoto K, Tanaka T, et al. Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology, 1992,39 : 433-436.
  • 10Dumont AE, Mulholland JH. Alteration in thoracic duct lymph flow in hepatic cirrhosis. Significance in portal hypertension. Ann. Surg, 1962,156:668-677.

共引文献21

同被引文献26

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部